{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:21:58Z","timestamp":1785770518684,"version":"3.56.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T00:00:00Z","timestamp":1559606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T00:00:00Z","timestamp":1559606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Korean Health Technology R&D Project, Ministry of Health and Welfare","award":["HI13C0016"],"award-info":[{"award-number":["HI13C0016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13075-019-1904-0","type":"journal-article","created":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T16:13:39Z","timestamp":1559664819000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Metformin improves salivary gland inflammation and hypofunction in murine Sj\u00f6gren\u2019s syndrome"],"prefix":"10.1186","volume":"21","author":[{"given":"Ji-Won","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Sil","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Hee","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JeongWon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Ah","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Geol","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon-Yeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Ki","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-La","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,4]]},"reference":[{"issue":"10","key":"1904_CR1","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/NEJMcp1702514","volume":"378","author":"X Mariette","year":"2018","unstructured":"Mariette X, Criswell LA. Primary Sjogren\u2019s syndrome. N Engl J Med. 2018;378(10):931\u20139.","journal-title":"N Engl J Med"},{"issue":"9","key":"1904_CR2","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nrrheum.2013.110","volume":"9","author":"G Nocturne","year":"2013","unstructured":"Nocturne G, Mariette X. Advances in understanding the pathogenesis of primary Sjogren\u2019s syndrome. Nat Rev Rheumatol. 2013;9(9):544\u201356.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"1904_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/BOR.0000000000000473","volume":"30","author":"E Pontarini","year":"2018","unstructured":"Pontarini E, Lucchesi D, Bombardieri M. Current views on the pathogenesis of Sjogren\u2019s syndrome. Curr Opin Rheumatol. 2018;30(2):215\u201321.","journal-title":"Curr Opin Rheumatol"},{"issue":"8","key":"1904_CR4","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI13505","volume":"108","author":"G Zhou","year":"2001","unstructured":"Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001;108(8):1167\u201374.","journal-title":"J Clin Invest"},{"issue":"7506","key":"1904_CR5","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature13270","volume":"510","author":"AK Madiraju","year":"2014","unstructured":"Madiraju AK, Erion DM, Rahimi Y, Zhang XM, Braddock DT, Albright RA, et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature. 2014;510(7506):542\u20136.","journal-title":"Nature."},{"issue":"3","key":"1904_CR6","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1530\/JOE-15-0447","volume":"228","author":"H An","year":"2016","unstructured":"An H, He L. Current understanding of metformin effect on the control of hyperglycemia in diabetes. J Endocrinol. 2016;228(3):R97\u2013106.","journal-title":"J Endocrinol"},{"key":"1904_CR7","doi-asserted-by":"publisher","first-page":"e224","DOI":"10.1038\/emm.2016.16","volume":"48","author":"J Kim","year":"2016","unstructured":"Kim J, Yang G, Kim Y, Kim J, Ha J. AMPK activators: mechanisms of action and physiological activities. Exp Mol Med. 2016;48:e224.","journal-title":"Exp Mol Med"},{"issue":"9","key":"1904_CR8","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","volume":"60","author":"G Rena","year":"2017","unstructured":"Rena G, Hardie DG, Pearson ER. The mechanisms of action of metformin. Diabetologia. 2017;60(9):1577\u201385.","journal-title":"Diabetologia"},{"issue":"1","key":"1904_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.intimp.2013.03.020","volume":"16","author":"KY Kang","year":"2013","unstructured":"Kang KY, Kim YK, Yi H, Kim J, Jung HR, Kim IJ, et al. Metformin downregulates Th17 cells differentiation and attenuates murine autoimmune arthritis. Int Immunopharmacol. 2013;16(1):85\u201392.","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"1904_CR10","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.4049\/jimmunol.1403088","volume":"198","author":"SY Lee","year":"2017","unstructured":"Lee SY, Moon SJ, Kim EK, Seo HB, Yang EJ, Son HJ, et al. Metformin suppresses systemic autoimmunity in Roquin (san\/san) mice through inhibiting B cell differentiation into plasma cells via regulation of AMPK\/mTOR\/STAT3. J Immunol. 2017;198(7):2661\u201370.","journal-title":"J Immunol"},{"issue":"9","key":"1904_CR11","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1007\/s00125-017-4352-x","volume":"60","author":"M Pollak","year":"2017","unstructured":"Pollak M. The effects of metformin on gut microbiota and the immune system as research frontiers. Diabetologia. 2017;60(9):1662\u20137.","journal-title":"Diabetologia"},{"issue":"6","key":"1904_CR12","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.2337\/db14-1225","volume":"64","author":"SB Vasamsetti","year":"2015","unstructured":"Vasamsetti SB, Karnewar S, Kanugula AK, Thatipalli AR, Kumar JM, Kotamraju S. Metformin inhibits monocyte-to-macrophage differentiation via AMPK-mediated inhibition of STAT3 activation: potential role in atherosclerosis. Diabetes. 2015;64(6):2028\u201341.","journal-title":"Diabetes"},{"issue":"3","key":"1904_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrrheum.2015.172","volume":"12","author":"A Perl","year":"2016","unstructured":"Perl A. Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases. Nat Rev Rheumatol. 2016;12(3):169\u201382.","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"1904_CR14","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.immuni.2009.04.014","volume":"30","author":"GM Delgoffe","year":"2009","unstructured":"Delgoffe GM, Kole TP, Zheng Y, Zarek PE, Matthews KL, Xiao B, et al. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity. 2009;30(6):832\u201344.","journal-title":"Immunity"},{"issue":"21","key":"1904_CR15","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1038\/sj.onc.1203476","volume":"19","author":"J Bromberg","year":"2000","unstructured":"Bromberg J, Darnell JE Jr. The role of STATs in transcriptional control and their impact on cellular function. Oncogene. 2000;19(21):2468\u201373.","journal-title":"Oncogene"},{"issue":"17","key":"1904_CR16","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1182\/blood-2011-11-392985","volume":"119","author":"CS Ma","year":"2012","unstructured":"Ma CS, Avery DT, Chan A, Batten M, Bustamante J, Boisson-Dupuis S, et al. Functional STAT3 deficiency compromises the generation of human T follicular helper cells. Blood. 2012;119(17):3997\u20134008.","journal-title":"Blood"},{"issue":"8","key":"1904_CR17","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1084\/jem.20151467","volume":"213","author":"CS Ma","year":"2016","unstructured":"Ma CS, Wong N, Rao G, Nguyen A, Avery DT, Payne K, et al. Unique and shared signaling pathways cooperate to regulate the differentiation of human CD4+ T cells into distinct effector subsets. J Exp Med. 2016;213(8):1589\u2013608.","journal-title":"J Exp Med"},{"issue":"3","key":"1904_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.immuni.2014.02.005","volume":"40","author":"JP Ray","year":"2014","unstructured":"Ray JP, Marshall HD, Laidlaw BJ, Staron MM, Kaech SM, Craft J. Transcription factor STAT3 and type I interferons are corepressive insulators for differentiation of follicular helper and T helper 1 cells. Immunity. 2014;40(3):367\u201377.","journal-title":"Immunity"},{"issue":"1","key":"1904_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1084\/jem.20091706","volume":"207","author":"DT Avery","year":"2010","unstructured":"Avery DT, Deenick EK, Ma CS, Suryani S, Simpson N, Chew GY, et al. B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J Exp Med. 2010;207(1):155\u201371.","journal-title":"J Exp Med"},{"issue":"12","key":"1904_CR20","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1084\/jem.20130323","volume":"210","author":"EK Deenick","year":"2013","unstructured":"Deenick EK, Avery DT, Chan A, Berglund LJ, Ives ML, Moens L, et al. Naive and memory human B cells have distinct requirements for STAT3 activation to differentiate into antibody-secreting plasma cells. J Exp Med. 2013;210(12):2739\u201353.","journal-title":"J Exp Med"},{"issue":"3","key":"1904_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jaut.2012.05.019","volume":"39","author":"N Singh","year":"2012","unstructured":"Singh N, Cohen PL. The T cell in Sjogren\u2019s syndrome: force majeure, not spectateur. J Autoimmun. 2012;39(3):229\u201333.","journal-title":"J Autoimmun"},{"key":"1904_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jaut.2017.11.003","volume":"87","author":"GM Verstappen","year":"2018","unstructured":"Verstappen GM, Corneth OBJ, Bootsma H, Kroese FGM. Th17 cells in primary Sjogren\u2019s syndrome: pathogenicity and plasticity. J Autoimmun. 2018;87:16\u201325.","journal-title":"J Autoimmun"},{"issue":"1","key":"1904_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/03009740701606010","volume":"37","author":"HL Ramos","year":"2008","unstructured":"Ramos HL, Valencia-Pacheco G, Alcocer-Varela J. Constitutive STAT3 activation in peripheral CD3(+) cells from patients with primary Sjogren\u2019s syndrome. Scand J Rheumatol. 2008;37(1):35\u20139.","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"1904_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/ard.2011.154013","volume":"71","author":"F Ciccia","year":"2012","unstructured":"Ciccia F, Guggino G, Rizzo A, Ferrante A, Raimondo S, Giardina A, et al. Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren\u2019s syndrome. Ann Rheum Dis. 2012;71(2):295\u2013301.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1904_CR25","doi-asserted-by":"publisher","first-page":"R64","DOI":"10.1186\/ar3780","volume":"14","author":"SK Kwok","year":"2012","unstructured":"Kwok SK, Cho ML, Her YM, Oh HJ, Park MK, Lee SY, et al. TLR2 ligation induces the production of IL-23\/IL-17 via IL-6, STAT3 and NF-kB pathway in patients with primary Sjogren\u2019s syndrome. Arthritis Res Ther. 2012;14(2):R64.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"1904_CR26","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/cei.12377","volume":"177","author":"SR Vartoukian","year":"2014","unstructured":"Vartoukian SR, Tilakaratne WM, Seoudi N, Bombardieri M, Bergmeier L, Tappuni AR, et al. Dysregulation of the suppressor of cytokine signalling 3-signal transducer and activator of transcription-3 pathway in the aetiopathogenesis of Sjogren\u2019s syndrome. Clin Exp Immunol. 2014;177(3):618\u201329.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"1904_CR27","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jconrel.2013.07.016","volume":"171","author":"M Shah","year":"2013","unstructured":"Shah M, Edman MC, Janga SR, Shi P, Dhandhukia J, Liu S, et al. A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjogren\u2019s syndrome. J Control Release. 2013;171(3):269\u201379.","journal-title":"J Control Release"},{"issue":"7","key":"1904_CR28","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1002\/art.21945","volume":"54","author":"MV Jonsson","year":"2006","unstructured":"Jonsson MV, Delaleu N, Brokstad KA, Berggreen E, Skarstein K. Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland. Arthritis Rheum. 2006;54(7):2300\u20135.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1904_CR29","doi-asserted-by":"publisher","first-page":"e432","DOI":"10.1038\/emm.2017.245","volume":"50","author":"EK Kim","year":"2018","unstructured":"Kim EK, Lee SH, Lee SY, Kim JK, Jhun JY, Na HS, et al. Metformin ameliorates experimental-obesity-associated autoimmune arthritis by inducing FGF21 expression and brown adipocyte differentiation. Exp Mol Med. 2018;50(1):e432.","journal-title":"Exp Mol Med"},{"issue":"2","key":"1904_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27\u201331.","journal-title":"J Basic Clin Pharm"},{"issue":"34","key":"1904_CR31","doi-asserted-by":"publisher","first-page":"12628","DOI":"10.1073\/pnas.0405099101","volume":"101","author":"GJ Shim","year":"2004","unstructured":"Shim GJ, Warner M, Kim HJ, Andersson S, Liu L, Ekman J, et al. Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren\u2019s syndrome. Proc Natl Acad Sci U S A. 2004;101(34):12628\u201333.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1904_CR32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.trsl.2016.03.006","volume":"173","author":"MJ Park","year":"2016","unstructured":"Park MJ, Lee SY, Moon SJ, Son HJ, Lee SH, Kim EK, et al. Metformin attenuates graft-versus-host disease via restricting mammalian target of rapamycin\/signal transducer and activator of transcription 3 and promoting adenosine monophosphate-activated protein kinase-autophagy for the balance between T helper 17 and Tregs. Transl Res. 2016;173:115\u201330.","journal-title":"Transl Res"},{"key":"1904_CR33","doi-asserted-by":"publisher","first-page":"973986","DOI":"10.1155\/2014\/973986","volume":"2014","author":"HJ Son","year":"2014","unstructured":"Son HJ, Lee J, Lee SY, Kim EK, Park MJ, Kim KW, et al. Metformin attenuates experimental autoimmune arthritis through reciprocal regulation of Th17\/Treg balance and osteoclastogenesis. Mediat Inflamm. 2014;2014:973986.","journal-title":"Mediat Inflamm"},{"issue":"4","key":"1904_CR34","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ni.2005","volume":"12","author":"GM Delgoffe","year":"2011","unstructured":"Delgoffe GM, Pollizzi KN, Waickman AT, Heikamp E, Meyers DJ, Horton MR, et al. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat Immunol. 2011;12(4):295\u2013303.","journal-title":"Nat Immunol"},{"issue":"1","key":"1904_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.immuni.2014.12.030","volume":"42","author":"J Blagih","year":"2015","unstructured":"Blagih J, Coulombe F, Vincent EE, Dupuy F, Galicia-Vazquez G, Yurchenko E, et al. The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo. Immunity. 2015;42(1):41\u201354.","journal-title":"Immunity"},{"key":"1904_CR36","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3389\/fimmu.2014.00590","volume":"5","author":"DJ Coe","year":"2014","unstructured":"Coe DJ, Kishore M, Marelli-Berg F. Metabolic regulation of regulatory T cell development and function. Front Immunol. 2014;5:590.","journal-title":"Front Immunol"},{"issue":"11","key":"1904_CR37","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nrd3531","volume":"10","author":"D Benjamin","year":"2011","unstructured":"Benjamin D, Colombi M, Moroni C, Hall MN. Rapamycin passes the torch: a new generation of mTOR inhibitors. Nat Rev Drug Discov. 2011;10(11):868\u201380.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"1904_CR38","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/art.23214","volume":"58","author":"CQ Nguyen","year":"2008","unstructured":"Nguyen CQ, Hu MH, Li Y, Stewart C, Peck AB. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjogren\u2019s syndrome: findings in humans and mice. Arthritis Rheum. 2008;58(3):734\u201343.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"1904_CR39","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1136\/ard.2004.031781","volume":"64","author":"JM van Woerkom","year":"2005","unstructured":"van Woerkom JM, Kruize AA, Wenting-van Wijk MJ, Knol E, Bihari IC, Jacobs JW, et al. Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjogren\u2019s syndrome compared with non-Sjogren\u2019s sicca syndrome. Ann Rheum Dis. 2005;64(10):1474\u20139.","journal-title":"Ann Rheum Dis"},{"key":"1904_CR40","first-page":"288","volume":"76","author":"B SLea","year":"2017","unstructured":"SLea B. Elevated MTORC1 signature in B cells from Sj\u00f6gren\u2019s syndrome patients correlates with B cell hyperactivity that is abrogated by MTOR inhibition: a novel therapeutic strategy to halt B cell hyperactivity in PSS? Ann Rheum Dis. 2017;76:288\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1904_CR41","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1002\/art.11311","volume":"48","author":"S Salomonsson","year":"2003","unstructured":"Salomonsson S, Jonsson MV, Skarstein K, Brokstad KA, Hjelmstrom P, Wahren-Herlenius M, et al. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjogren\u2019s syndrome. Arthritis Rheum. 2003;48(11):3187\u2013201.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1904_CR42","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.semarthrit.2012.07.003","volume":"42","author":"AP Risselada","year":"2013","unstructured":"Risselada AP, Looije MF, Kruize AA, Bijlsma JW, van Roon JA. The role of ectopic germinal centers in the immunopathology of primary Sjogren\u2019s syndrome: a systematic review. Semin Arthritis Rheum. 2013;42(4):368\u201376.","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"1904_CR43","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nrrheum.2016.217","volume":"13","author":"M Bombardieri","year":"2017","unstructured":"Bombardieri M, Lewis M, Pitzalis C. Ectopic lymphoid neogenesis in rheumatic autoimmune diseases. Nat Rev Rheumatol. 2017;13(3):141\u201354.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"1904_CR44","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.clim.2013.02.024","volume":"147","author":"K Szabo","year":"2013","unstructured":"Szabo K, Papp G, Barath S, Gyimesi E, Szanto A, Zeher M. Follicular helper T cells may play an important role in the severity of primary Sjogren\u2019s syndrome. Clin Immunol. 2013;147(2):95\u2013104.","journal-title":"Clin Immunol"},{"issue":"5","key":"1904_CR45","first-page":"1988","volume":"7","author":"L Jin","year":"2014","unstructured":"Jin L, Yu D, Li X, Yu N, Li X, Wang Y, et al. CD4+CXCR5+ follicular helper T cells in salivary gland promote B cells maturation in patients with primary Sjogren\u2019s syndrome. Int J Clin Exp Pathol. 2014;7(5):1988\u201396.","journal-title":"Int J Clin Exp Pathol"},{"key":"1904_CR46","first-page":"69","volume":"2","author":"T Fujimura","year":"2015","unstructured":"Fujimura T, Fujimoto T, Itaya-Hironaka A, Miyaoka T, Yoshimoto K, Yamauchi A, et al. Interleukin-6\/STAT pathway is responsible for the induction of gene expression of REG Ialpha, a new auto-antigen in Sjogren\u2019s syndrome patients, in salivary duct epithelial cells. Biochem Biophys Rep. 2015;2:69\u201374.","journal-title":"Biochem Biophys Rep"},{"issue":"1","key":"1904_CR47","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1038\/s41467-018-04974-3","volume":"9","author":"CJ Zhang","year":"2018","unstructured":"Zhang CJ, Wang C, Jiang M, Gu C, Xiao J, Chen X, et al. Act1 is a negative regulator in T and B cells via direct inhibition of STAT3. Nat Commun. 2018;9(1):2745.","journal-title":"Nat Commun"},{"issue":"8","key":"1904_CR48","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.2337\/db11-0373","volume":"60","author":"D Ize-Ludlow","year":"2011","unstructured":"Ize-Ludlow D, Lightfoot YL, Parker M, Xue S, Wasserfall C, Haller MJ, et al. Progressive erosion of beta-cell function precedes the onset of hyperglycemia in the NOD mouse model of type 1 diabetes. Diabetes. 2011;60(8):2086\u201391.","journal-title":"Diabetes"},{"issue":"11","key":"1904_CR49","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.2337\/db15-0449","volume":"64","author":"CE Mathews","year":"2015","unstructured":"Mathews CE, Xue S, Posgai A, Lightfoot YL, Li X, Lin A, et al. Acute versus progressive onset of diabetes in NOD mice: potential implications for therapeutic interventions in type 1 diabetes. Diabetes. 2015;64(11):3885\u201390.","journal-title":"Diabetes"},{"issue":"3","key":"1904_CR50","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/ar3313","volume":"13","author":"N Delaleu","year":"2011","unstructured":"Delaleu N, Nguyen CQ, Peck AB, Jonsson R. Sjogren\u2019s syndrome: studying the disease in mice. Arthritis Res Ther. 2011;13(3):217.","journal-title":"Arthritis Res Ther"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1904-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-019-1904-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1904-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T23:15:45Z","timestamp":1591139745000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-019-1904-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,4]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1904"],"URL":"https:\/\/doi.org\/10.1186\/s13075-019-1904-0","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,4]]},"assertion":[{"value":"14 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental procedures were examined and approved by the Animal Research Ethics Committee of the Catholic University of Korea (permit number: CUMC-2016-0264-02) and conformed to all applicable US National Institutes of Health guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"136"}}